Previous Article | Next Article ![]()
Journal of Virology, May 2005, p. 5676-5683, Vol. 79, No. 9
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.9.5676-5683.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, New York University School of Medicine, New York, New York 10016
Received 11 October 2004/ Accepted 8 December 2004
|
|
|---|
|
|
|---|
The protein 100k is a late adenovirus polypeptide encoded by the L4 transcription unit in very large amounts (15). 100k is the first late viral protein translated with the onset of the late phase of infection (3). Recent studies showed that 100k protein is largely responsibly for inhibition of cellular protein synthesis (25), and it is also involved in promoting translation on tripartite leader mRNAs by ribosome shunting (25). 100k binds the carboxyl terminus of eIF4G at or near the site normally occupied by the kinase Mnk1, which is responsible for phosphorylating cap binding protein eIF4E. 100k therefore competitively displaces Mnk1 from cap initiation complexes, which prevents eIF4E phosphorylation (4). Dephosphorylation of eIF4E is often associated with inhibition of cellular cap-dependent mRNA translation, although the mechanism is not understood. 100k protein also binds mRNAs in the cytoplasm (1, 20) and demonstrates a preference for late Ad tripartite leader mRNAs (25). The C terminus of 100k (amino acid 726 to 805) contains a general RNA-binding domain, whereas its middle region (345 to 726) contains a tripartite leader-specific mRNA binding domain (25). During late viral infection, the modified 100k cap initiation complex associates with higher specificity to mRNAs that contain the tripartite leader 5' NCR. The 100k-tripartite leader complex enhances association with the initiation factor 4G (eIF4G) and poly(A) binding protein, which is associated with increased translation by ribosome shunting on late viral mRNAs (25).
Ad protein 100k is a tyrosine- and serine-phosphorylated protein (10). In addition, Ad stimulates tyrosine kinase activity during the late phase of infection, which has been linked to inhibition of cellular protein synthesis (9). To investigate whether the ability of Ad 100k protein to promote ribosome shunting and/or inhibit cellular protein synthesis is regulated by tyrosine phosphorylation, we performed biochemical and mutational studies of 100k protein. We show that tyrosine phosphorylation does not affect 100k protein association with eIF4G. Rather, tyrosine dephosphorylation of 100k protein at sites Y365 and Y682 is shown to impair its ability to promote ribosome shunting on Ad late mRNAs by decreasing 100k-RNA interaction. In addition, tyrosine phosphorylation was found to promote ribosome shunting by enhancing preferential binding of 100k protein to tripartite leader mRNAs. 100k protein therefore links the requirement for tyrosine kinase activity during late Ad infection to translational control.
|
|
|---|
Plasmids. Plasmid pCMV-Adß-gal (8), pCMV-CR3ß-gal, pTL-Flag100kN726, pTL-Flag100kN345, pTL-100kY365F, pCMV-LUC, and pCMV-AdB202LUC (25) were described previously. pFLAG-CM2 was from Sigma. pIRES-EGFP was from Clontech. pTL-Flag100kY365FY682F (renamed Flag100kYYF) and pTL-Flag100kN726Y365FY368F (renamed 100kN726YYF) were constructed by inserting a BstEII-AscI 100k DNA fragment containing an aa 365Y-to-F mutation into BstEII-AscI-digested pTL-Flag100kY682F and pTL-Flag100kN726Y682F vectors, respectively. Plasmids pTL-Flag100kY682F and pTL-Flag100N726Y682F were derived from pTL-Flag100k and pTL-Flag100kN726 using a site-directed mutagenesis kit (Stratagene). The primers for cloning were 100kY682F (5'-end oligo; 5'-CGAAAGGGACGGGGGGTTTTCCTGGACCCCCAGTCC-3') and 100kY682F (3'-end oligo; 5'-GCCGGACTGGGGGTCCAGGAAAACCCCCCGTCCCTTTCG-3'). All of the plasmids were confirmed by DNA sequencing.
Mammalian cell transfection and luciferase assay. 293 cells were transfected with plasmid constructs using Lipofectamine Plus (Invitrogen) according to manufacturer protocols. Cells were harvested 36 h posttransfection and subjected to detergent lysis (0.5% NP-40, 50 mM HEPES, pH 7.0, 250 mM NaCl, 2 mM EDTA, 2 mM sodium orthovanadate, 25 mM glycerophosphate, 1 tablet of protease inhibitor [Roche] per 10 ml) at 4°C for 20 min, nuclei were pelleted by microcentrifuge centrifugation, and supernatant lysates were collected. Luciferase assays were performed as per manufacturer protocol (Promega).
Immunoprecipitation and immunoblot analysis. Equal amounts of lysates were incubated with 2 µg mouse monoclonal antibodies to FLAG (Sigma) for 1 h at 4°C or 20 µl rabbit polyclonal serum against the C-terminal fragment of eIF4G (4) and RNase A (20 µg/ml) overnight at 4°C. Either protein G or A agarose was added and incubated for 1 h at 4°C. Precipitates were washed four times with lysis buffer, boiled in sodium dodecyl sulfate (SDS)-sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 25% glycerol, 0.01% bromophenol blue), and analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). Gels were electroblotted onto Immunobilon-P membrane (Millipore) and blocked overnight in blocking buffer (150 mM NaCl, 10 mM Tris-HCl, pH 8.0, 5% bovine serum albumin at 4°C). Primary antibodies used were mouse monoclonal anti-phosphotyrosine antibody (1:500), mouse monoclonal anti-FLAG antibody (1 µg/ml), and rabbit polyclonal serum against the C terminus of eIF4G (1:250). Studies used horseradish peroxidase-conjugated donkey anti-rabbit or sheep anti-mouse secondary antibodies or horseradish peroxidase-conjugated protein A (1:5,000) as secondary antibody. An enhanced chemiluminescence detection method (Amersham) was used, and the membrane was exposed to film.
Northern blot analysis.
293 cells were lysed directly into Trizol extraction reagent (Invitrogen). RNA samples were electrophoresed on a denaturing formaldehyde gel and transferred to a nylon membrane (Perkin Elmer Life Science, Inc.). Membranes were probed overnight at 68°C with [
-32P]dCTP-labeled probes directed to the ß-galactosidase and GAPDH coding regions. Following washes, membranes were exposed to film at 70°C.
In vivo RNA-binding assay. 293 cells were lysed directly into detergent lysis buffer (0.5% NP-40, 50 mM HEPES, pH 7.0, 250 mM NaCl, 2 mM EDTA, 2 mM sodium orthovanadate, 25 mM glycerophosphate, 1 tablet of protease inhibitor [Roche] per 10 ml, and 40 U/ml Rnasin [Promega]) at 4°C for 20 min, nuclei were pelleted by centrifugation, and supernatant lysates were collected. Wild-type or mutant 100k protein was recovered from equal amounts of lysate by immunoprecipitation with anti-FLAG antibody using lysis buffer. mRNAs were extracted from the immunoprecipitated protein using Trizol extraction reagent. Semiquantitative reverse transcription-PCR (RT-PCR) amplification of immunoprecipitated ß-galactosidase (ß-gal) mRNA was carried out as described previously (22).
|
|
|---|
![]() View larger version (23K): [in a new window] |
FIG. 1. Genistein impairs promotion of ribosome shunting by Ad 100k protein. (A) Diagrammatic representation of the B202 form of the tripartite leader is shown. Insertion of a stable ( -70 kcal/mol) hairpin between the 3' end of the tripartite leader and the reporter AUG initiation codon blocks initiation by 5' to 3' ribosome scanning and only allows initiation by ribosome shunting. (B and C) 293 cells were cotransfected with vector alone (pFLAG-CM2) or vectors expressing Flag-tagged wild-type 100k protein (pTLFLAG100), a luciferase reporter encoded by an mRNA containing the Ad B202 tripartite leader 5' NCR mutant, and the GFP protein controlled by the EMCV IRES (pIRES-EGFP). Transfected cells were treated with genistein (300 µM) or PP2 (30 µM) posttransfection or were mock treated. At 36 h posttransfection, cells were collected and lysates and total RNAs were prepared. (B) Wild-type 100k was recovered from equal amounts of lysates by immunoprecipitation with anti-Flag antibody. 100k protein complexes were analyzed by immunoblotting using anti-FLAG and anti-phosphotyrosine (P-Tyr) antibodies. Immunoprecipitations were performed with anti-C-terminal eIF4G antibodies (c-eIF4G antibody). eIF4G immune complexes were analyzed by immunoblotting using anti-c-eIF4G and anti-Flag antibodies. V, vector alone control. (C) Luciferase activity was measured after normalizing to similar reporter mRNA levels by Northern blotting and protein lysate amounts. Autoradiograms were quantified by densitometry, and typical results are shown. Standard deviations were calculated from at least three independent experiments.
|
These data suggest that tyrosine phosphorylation of 100k might play a role in its ability to promote ribosome shunting. These results also suggest that the key regulatory phosphotyrosines in 100k protein are predominantly phosphorylated by kinases other than Src, since PP2 specifically inhibits Src kinase activity (21) and had little effect on 100k ribosome shunting activity.
100k protein phosphotyrosine sites are located between aa 345 and aa 726. To determine whether 100k tyrosine phosphorylation directly regulates its activity in translational control, we first identified the major sites of tyrosine phosphorylation. 100k protein has 21 tyrosines, several of which are within strong consensus sites for phosphorylation. The regions in 100k that are most heavily tyrosine phosphorylated were preliminarily mapped by utilizing 100k protein truncation mutants 100kN726 and 100kN345 (Fig. 2A). Plasmids expressing wild-type or mutant Flag-100k proteins were transfected into 293 cells. At 32 h posttransfection, cells were treated with 150 µM genistein or with vehicle control for 4 h before lysis. Wild-type or mutant 100k protein was recovered from equal amounts of cell lysates by immunoprecipitation with anti-Flag antibody. 100k proteins were analyzed by SDS-PAGE and immunoblot analysis using anti-Flag and anti-phosphotyrosine (P-Tyr) antibodies (Fig. 2B). Mutant 100kN726 protein was found to be tyrosine phosphorylated to the same extent as wild-type 100k protein (Fig. 2B, lanes 2 and 3), whereas no tyrosine phosphorylation signal was detected in the 100kN345 protein (Fig. 2B, lanes 4 and 8). Genistein treatment significantly decreased the tyrosine phosphorylation level of wild-type and N726 100k proteins (approximately five- to ninefold) (Fig. 2B, lanes 6 and 7). These results suggest that the tyrosine phosphorylation sites in protein 100k are located between amino acids 345 and 726.
![]() View larger version (50K): [in a new window] |
FIG. 2. 100k protein phosphotyrosine sites are located between aa 345 and aa 726. (A) Schematic representation of Ad 100k protein functional domains. The N terminus is responsible for Ad 100k protein inhibition of cellular mRNA translation, the middle region contains a virus-specific RNA-binding domain, and the C-terminal domain contains a general RNA-binding domain. (B) 293 cells were transfected with vector alone (pFLAG-CM2) or vector pFlag-TL100k, pFlag-TL100kN726, or pFlag-TL100kN345. At 32 h posttransfection, cells were treated with or without 150 µM genistein for 4 h before lysis. Wild-type or mutant 100k protein was recovered from equal amounts of lysate by immunoprecipitation with anti-Flag antibody. 100k protein complexes were analyzed by immunoblot using anti-Flag and anti-phosphotyrosine (P-Tyr) antibodies. Autoradiograms were quantified by densitometry and typical results are shown.
|
50%) in their ability to promote ribosome shunting compared to wild-type 100k protein (Fig. 3C). Taken together, these data indicate that 100k protein undergoes tyrosine phosphorylation at both aa 365 and aa 682, and mutation of either site independently and moderately impairs 100k protein ability to promote ribosome shunting.
![]() View larger version (37K): [in a new window] |
FIG. 3. Mutations of tyrosines at aa 365 and aa 682 in 100k protein disable its ability to promote ribosome shunting. (A) 293 cells were cotransfected with plasmid pIRES-EGFP, vector alone, or pFlag-TL100k, pFlag-TL100kY365F, or pFlag-TL100kY682F, and a plasmid expressing luciferase reporter mRNA containing the mutant tripartite leader 5' NCR (B202) that translates solely by ribosome shunting. Wild-type or mutant 100k protein was recovered from equal amounts of lysate by immunoprecipitation with anti-Flag antibody. 100k protein complexes were analyzed by immunoblotting using anti-Flag and anti-phosphotyrosine (P-Tyr) antibodies. (B) 293 cells were cotransfected with pIRES-EGFP, vector alone, pFlag-TL100k, or pFlag-TL100kYYF, and a plasmid expressing tripartite leader B202 luciferase mRNA. Wild-type or mutant 100k protein was recovered from equal amounts of lysate and processed as described above. (C) Luciferase activity was measured after normalization to similar reporter mRNA levels by Northern blotting. Autoradiograms were quantified by densitometry, and typical results are shown. Standard deviations were calculated from at least three independent experiments.
|
100k protein tyrosine mutants associate with eIF4G to the same level as wild-type 100k protein. To investigate the role of tyrosine phosphorylation in 100k protein association with eIF4G, wild-type or mutant 100k proteins were expressed in 293 cells from transfected plasmids. Lysates were prepared 36 h posttransfection, and endogenous eIF4G was recovered from equal amounts of RNase A-treated lysates by immunoprecipitation with anti-eIF4G antibody. The eIF4G complex was analyzed by immunoblotting using anti-Flag and anti-eIF4G antibodies. RNase A treatment assured that 100k protein association with eIF4G occurred independently of RNA binding, and it must occur by direct protein-protein interaction. The tyrosine mutant 100k proteins associated with eIF4G to an extent similar to that of the wild-type 100k protein (Fig. 4). Transfection of smaller amounts of plasmid DNA, resulting in lower expression of proteins, did not alter the interaction results (data not shown). These data indicate that tyrosine phosphorylation of 100k protein does not affect 100k protein association with eIF4G, and results were not obscured by protein overexpression.
![]() View larger version (37K): [in a new window] |
FIG. 4. 100k protein tyrosine mutants associate with eIF4G equally well as wild-type 100k. 293 cells were transfected with vector alone, pFlag-TL100k, pFlag-TL100kY365F, pFlag-TL100kY682F, or pFlag-TL100kYYF. eIF4G was recovered from equal amounts of RNase A-treated lysates by immunoprecipitation with anti-C-eIF4G antibody. eIF4G complexes were analyzed by immunoblotting using anti-Flag and anti-c-eIF4G antibodies.
|
![]() View larger version (53K): [in a new window] |
FIG. 5. Genistein treatment abolishes the ability of 100kN726 protein to preferentially bind tripartite leader mRNA. 293 cells were cotransfected with vector alone, pFlag-TL100k, pFlag-TL100kN726, pFlag-TL100kN726YYF, and plasmids expressing ß-gal mRNA containing either the wild-type tripartite leader (3LDR) or an eIF4F-dependent 5' NCR (CR3). Cells were treated with or without 300 µM genistein for 4 h and then lysed. Wild-type or mutant 100k proteins were recovered from equal amounts of lysate by immunoprecipitation with anti-Flag antibody. (A) Immunoprecipitated protein was analyzed by immunoblot with anti-p-Y and anti-Flag antibodies. (B) mRNA was extracted from the immunoprecipitated protein and identified by reverse transcription followed by semiquantitative PCR (RT-PCR). (C) Total RNA was isolated from lysates, and 3LDR mRNAs and CR3 mRNAs were determined by Northern blot analysis. Autoradiograms were quantified by densitometry, and typical results are shown.
|
![]() View larger version (55K): [in a new window] |
FIG. 6. Mutant 100kYYF fails to associate with viral mRNA. 293 cells were cotransfected with vector alone or pFlag-TL100kN726, pFlag-TL100kYYF, and plasmids expressing ß-gal mRNA containing either the wild-type tripartite leader (3LDR) or an eIF4F-dependent 5' NCR (CR3). Cells were treated with or without 300 µM genistein for 4 h before lysis. Mutant 100k proteins were recovered from equal amounts of lysate by immunoprecipitation with anti-Flag antibody. (A) The immunoprecipitated protein was analyzed by immunoblot with anti-p-Y and anti-Flag antibodies. (B) mRNA was extracted from the immunoprecipitated protein and identified by reverse transcription followed by quantitative PCR (RT-PCR). (C) Total RNA was isolated from lysates. 3LDR and CR3 mRNAs amounts were determined by Northern blot analysis. Autoradiograms were quantified by densitometry, and typical results are shown.
|
|
|
|---|
Earlier work has shown that genistein, a broad-spectrum tyrosine kinase inhibitor, decreases late Ad protein synthesis during viral infection and prevents inhibition of host cell mRNA translation. These data suggested that tyrosine kinase activity plays a role in the regulation of late Ad protein synthesis (9). Cytoplasmic 100k protein is tyrosine phosphorylated, and its tyrosine phosphorylation level strongly decreases after genistein treatment (Fig. 1B). Since PP2, a Src kinase-specific inhibitor, did not prevent 100k protein from promoting ribosome shunting whereas genistein did (Fig. 1A), these data indicate that the function of late Ad 100k protein is to promote ribosome shunting in a manner regulated by non-Src tyrosine phosphorylation. It is possible that genistein affects factors other than Ad 100k protein, such as translation initiation factors that are involved in ribosome shunting. However, we found that single tyrosine mutation at aa 365 or aa 682 caused moderate defects in promoting ribosome shunting (Fig. 3C) and that mutation of both tyrosines nearly abolished the ability of 100k to promote ribosome shunting (Fig. 3B and C). Furthermore, the extent of inhibition of 100k mediated ribosome shunting activity correlated with decreased tyrosine phosphorylation in the corresponding mutants (Fig. 3). It is important to note that these data do not fully exclude the possibility that tyrosine phosphorylation of non-Ad proteins might be involved in ribosome shunting or that mutation of the phosphorylated tyrosines might alter 100k structure, thereby impairing its activity. However, several lines of evidence all support the most straightforward interpretation that Ad 100k protein tyrosine phosphorylation is important for promoting ribosome shunting.
Tyrosine kinase signaling is stimulated shortly after Ad enters the late phase of infection (9), and cytoplasmic 100k protein is tyrosine phosphorylated (10) (as shown here). The late phase of Ad infection is marked by the onset of viral DNA replication, from 8 to 14 h after infection (24), when most structural proteins involved in production of viral particles are synthesized. The functional significance of regulating ribosome shunting by tyrosine phosphorylation of 100k protein in the cytoplasm might be to link enhanced synthesis of viral structural proteins to viral-induced cell stress responses, which would enable rapid production of viral particles before the death of Ad-infected cells. It should also be noted that although E1A and E1B protein activities on translation and mRNA transport might influence tripartite leader-100k interaction, we suspect that there is no critical requirement for early proteins in 100k translation activity. 100k was found to stimulate tripartite leader-directed translation in HeLa cells which do not express E1A and E1B (data not shown). It is also not known which protein tyrosine kinase phosphorylates 100k protein at positions Y365 and Y682. The tyrosine phosphorylation site characterizes a fairly general consensus site and could in fact be targeted by multiple tyrosine kinases.
There are a growing number of proteins whose ability to function in RNA binding is regulated by tyrosine phosphorylation (11, 13, 17, 28). While tyrosine phosphorylation of 100k protein increases its affinity to viral RNA, some RNA-binding proteins demonstrate a decrease in RNA-binding ability upon tyrosine phosphorylation (13, 17, 28). The pp68 protein SYNCRIP/NSAP1 (synaptotagmin-binding cytoplasmic RNA-interacting protein) may involved in regulation of mRNA translation or stability by insulin, and it is regulated by tyrosine phosphorylation (11). The MnSOD-BP protein (manganese superoxide dismutase TNA-binding protein) regulates MnSOD activity and is also regulated by its tyrosine phosphorylation states (13). Moreover, the mechanism by which hnRNPK acts as a translational silencer of human papilloma virus type 16 (HPV-15) L2 capsid protein and reticulocyte 15-lipooxygenase (LOX) occurs by blocking 60S ribosome subunits from joining 40S subunits, and it is regulated by c-Src (16). c-Src mediates tyrosine phosphorylation of hnRNPK and inhibits its RNA-binding activity, leading to activation of translation (17). QK1, a selective RNA-binding protein which belongs to the protein family known as signal transduction activator of RNA (STAR), is essential for myelination in the central nervous system. Tyrosine phosphorylation of QK1 was shown to be involved in regulating mRNA stability (28). The mechanism by which tyrosine phosphorylation regulates RNA-binding is not known in any of these examples or for Ad 100k protein. However, since two mutants which converted the key tyrosine sites of 100k to aspartic acid (100kY365D and 100kY682D) failed to promote ribosome shunting (data not shown), it is likely that a negative charge created by tyrosine phosphorylation is not in itself important for increasing 100k protein RNA-binding ability. 100k protein can dimerize (unpublished data), and it is possible that dimeric 100k protein is the form that binds to RNA, as found for several other RNA binding proteins (18, 19). However, all of the tyrosine mutants (100kY365F, 100kY682F, 100kYYF, 100kY365D, 100kY682D, and 100kYYD) dimerize to the same extent as wild-type 100k protein (data not shown), despite the fact that for those mutants tyrosine phosphorylation levels decreased compared to wild type 100k protein. Thus, it is therefore more likely that tyrosine phosphorylation of 100k protein is essential for maintaining certain conformational changes or interactions that confer on the protein the ability to bind to RNA.
Present address: Centre de Regulacio Genomica, Passeig Maritim, 08003 Barcelona, Spain. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»